Not finding it? Sign in to also search OpenAlex live.
-
Effectiveness of longstanding exercise therapy compared with usual care for people with rheumatoid arthritis and severe functional limitations: a randomised controlled trial2024 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
M. Teuwen, Salima F. E. van Weely, T. P. M. Vliet Vlieland, MAT van Wissen, Wilfred F. Peter, Alfons A den Broeder, +4 more
31citations -
POS0198 EFFICACY AND SAFETY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE TYROSINE KINASE 2 INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL2021 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access cited by 1 patent
Philip J. Mease, Atul A. Deodhar, Désirée van der Heijde, Frank Behrens, Alan Kivitz, J. Kim, +3 more
15citations -
SAT0158 EFFICACY AND SAFETY OF FILGOTINIB IN METHOTREXATE-NAÏVE PATIENTS WITH RHEUMATOID ARTHRITIS: FINCH 3 52-WEEK RESULTS2020 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
René Westhovens, WFC Rigby, Désirée van der Heijde, William Stohl, Jonathan Kay, A Chopra, +11 more
8citations -
POS1027 EFFICACY AND SAFETY OF GUSELKUMAB, A MONOCLONAL ANTIBODY SPECIFIC TO THE p19-SUBUNIT OF INTERLEUKIN-23, THROUGH 2 YEARS: RESULTS FROM A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY CONDUCTED IN BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS2021 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Iain B. McInnes, Proton Rahman, A.B. Gottlieb, E.C. Hsia, Alexa P. Kollmeier, X. L. Xu, +6 more
4citations -
The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosis2023 Journal of Scleroderma and Related Disorders article Medicine Systemic Sclerosis and Related Diseases Open access
Sophie I E Liem, Sytske Anne Bergstra, Jacopo Ciaffi, Coen van der Meulen, David A Ueckert, Rita Schriemer, +3 more
4citations -
OP0227 EFFICACY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE TYROSINE KINASE 2 INHIBITOR, IN MUSCULOSKELETAL MANIFESTATIONS OF ACTIVE PSORIATIC ARTHRITIS IN A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL2021 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments cited by 1 patent
Philip J. Mease, Atul A. Deodhar, Désirée van der Heijde, Frank Behrens, Alan Kivitz, Thomas Lehman, +3 more
3citations -
AB0167 FUNCTIONAL DISABILITIES IN HANDS PRECEDE THOSE IN FEET IN PATIENTS PROGRESSING FROM CLINICALLY SUSPECT ARTHRALGIA TO RHEUMATOID ARTHRITIS; A LONGITUDINAL OBSERVATIONAL STUDY2022 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Sarah J H Khidir, Erik M. van Mulligen, A. van der Helm-van Mil
3citations -
FRI0115 FILGOTINIB PROVIDED RAPID AND SUSTAINED IMPROVEMENTS IN FUNCTIONAL STATUS, PAIN, AND HEALTH-RELATED QUALITY OF LIFE, AND REDUCED FATIGUE OVER TIME IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO ARE METHOTREXATE-NAÏVE: RESULTS FROM THE FINCH 3 STUDY2020 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies
Rieke Alten, William F. C. Rigby, Alena Pechonkina, Ken Hasegawa, Thijs K. Hendrikx, Tatsuya Atsumi, +1 more
3citations -
POS0676 EFFICACY AND SAFETY OF FILGOTINIB IN PATIENTS AGED ≥75 YEARS: A POST HOC SUBGROUP ANALYSIS OF THE FINCH 4 LONG-TERM EXTENSION (LTE) STUDY2022 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Daniel Aletaha, R. Westhovens, B. Combe, Jacques‐Eric Gottenberg, M. H. Buch, R. Caporali, +7 more
3citations -
FRI0128 FILGOTINIB PROVIDED RAPID AND SUSTAINED IMPROVEMENTS IN FUNCTIONAL STATUS, PAIN, HEALTH-RELATED QUALITY OF LIFE, AND FATIGUE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE: RESULTS FROM THE FINCH 1 STUDY2020 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Alan Kivitz, Yoshiya Tanaka, S. Lee, L. Ye, Hao Hu, Robin Besuyen, +1 more
3citations -
POS1043 STRONG CORRELATION BETWEEN SHORT- VS LONG-FORM COMPOSITE MEASURES OF PSORIATIC ARTHRITIS DISEASE ACTIVITY IN A TNFi-IR POPULATION TREATED WITH GUSELKUMAB: DATA FROM THE PHASE 3b COSMOS TRIAL2022 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
William L. Tillett, L. Coates, M. Neuhold, E. Theander, P. Bergmans, M. Shawi, +3 more
2citations -
OP0232 FEMALE VERSUS MALE BURDEN OF PSORIATIC ARTHRITIS IS HIGHER AND TREATMENT PERSISTENCE SHORTER AFTER USTEKINUMAB OR TUMOUR NECROSIS FACTOR INHIBITOR TREATMENT: 1-YEAR DATA FROM THE PSABIO STUDY2021 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Irene E. van der Horst-Bruinsma, Michael Twahier Nurmohamed, Anne van Kuijk, Stefan Siebert, Paul Bergmans, Kurt de Vlam, +8 more
1citations -
POS1035 LOW RATES OF RADIOGRAPHIC PROGRESSION WITH 2 YEARS OF GUSELKUMAB, A SELECTIVE INHIBITOR OF THE INTERLEUKIN-23p19 SUBUNIT: RESULTS FROM A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS2022 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Philip J. Mease, A.B. Gottlieb, Iain B. McInnes, Proton Rahman, Alexa P. Kollmeier, X. L. Xu, +6 more
1citations -
SAT0104 MAINTENANCE OF SDAI REMISSION AND PATIENT-REPORTED OUTCOMES (PROS) FOLLOWING DOSE DE-ESCALATION OF ABATACEPT IN MTX-NAÏVE, ANTI-CITRULLINATED PROTEIN ANTIBODY (ACPA)+ PATIENTS WITH EARLY RA: RESULTS FROM AVERT-2, A RANDOMISED PHASE IIIB STUDY2020 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
Paul E. Emery, Yoshiya Tanaka, Vivian P. Bykerk, Tom W. J. Huizinga, Gustavo Citera, C.O. Bingham, +8 more
1citations -
AB0806 THE LONG-TERM COURSE OF THE HEALTH ASSESSMENT QUESTIONNAIRE IN PATIENTS WITH SYSTEMIC SCLEROSIS2023 Annals of the Rheumatic Diseases conference-abstract Medicine Systemic Sclerosis and Related Diseases Open access
Sophie I E Liem, Sytske Anne Bergstra, Jacopo Ciaffi, Coen van der Meulen, D. Ueckert, Rixt Schriemer, +3 more
0citations -
AB0689 SUSTAINED PATIENT MEANINGFUL OUTCOMES OF PAIN AND FATIGUE RELIEF AND IMPROVED PHYSICAL FUNCTIONING WITH FILGOTINIB IN RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS2024 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies
R. Alten, Bruno Fautrel, Philip G. Conaghan, D. de Vries, K. Van Beneden, Chris Watson, +3 more
0citations -
POS1472-HPR CONSTRUCT VALIDITY OF THE PROMIS PHYSICAL FUNCTION 10-ITEM SHORT FORM IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES AND SEVERE LIMITATIONS IN PHYSICAL FUNCTIONING2022 Annals of the Rheumatic Diseases article Decision Sciences Psychometric Methodologies and Testing Open access
B. Straathof, M. Van Wissen, T. P. M. Vliet Vlieland, C. van den Ende, M. Teuwen, W. F. Peter, +6 more
0citations -
POS0865 THE EFFECT OF SILVER FIBER GLOVES ON RAYNAUD'S PHENOMENON IN PATIENTS WITH SYSTEMIC SCLEROSIS: A DOUBLE-BLIND RANDOMIZED CROSS-OVER TRIAL.2022 Annals of the Rheumatic Diseases conference-abstract Medicine Systemic Sclerosis and Related Diseases Open access
Sophie I E Liem, E. Hoekstra, F. Bonte-Mineur, C. Magro Checa, A. Schouffoer, C. Allaart, +3 more
0citations -
POS0658 GEOGRAPHIC VARIATION OF EFFICACY IN THE FILGOTINIB RHEUMATOID ARTHRITIS PROGRAM2021 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Maya H Buch, Tsukasa Matsubara, B. Combe, Alena Pechonkina, YingMeei Tan, Robin Besuyen, +1 more
0citations -
POS1046 IMPROVEMENTS IN PATIENT-REPORTED IMPACT OF PSORIATIC ARTHRITIS WITH IL-12/23 (USTEKINUMAB) OR TUMOUR NECROSIS FACTOR INHIBITORS: 1-YEAR DATA FROM THE LARGE, REAL-WORLD PsABIO STUDY2021 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Laure Gossec, Stefan Siebert, Paul Bergmans, Kurt de Vlam, Elisa Gremese, Beatriz E. Joven-Ibáñez, +6 more
0citations -
POS0589-HPR NATURE AND SEVERITY OF FUNCTIONAL LIMITATIONS ACCORDING TO THE HEALTH ASSESSMENT QUESTIONNAIRE DISABILITY INDEX IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SEVERE FUNCTIONAL DISABILITY2023 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
MAT van Wissen, Maaike G. J. Gademan, Cornelia H. M. van den Ende, M. Teuwen, Wilfred F. Peter, D. van Schaardenburg, +3 more
0citations -
Efficacité et tolérance du filgotinib chez les patients atteints de polyarthrite rhumatoïde (PR) présentant une réponse inadéquate au méthotrexate (RI-MTX) : résultats de l’étude FINCH 1 à 52 semaines
Bernard G Combe, Alan Kivitz, Yoshiya Tanaka, Désirée van der Heijde, Jesus Abraham Simón Campos, Herbert S. B. Baraf, +12 more
0citations -
FRI0139 FILGOTINIB PROVIDED RAPID AND SUSTAINED RELIEF OF PAIN AND FATIGUE AND IMPROVED HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC DMARDS: RESULTS FROM THE FINCH 2 STUDY2020 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies
David Walker, Tsutomu Takeuchi, Beatrix Bartók, I. H. Lee, Robin Besuyen, J.E. Gottenberg, +1 more
0citations -
THU0188 EFFICACY OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH POOR PROGNOSTIC FACTORS: POST HOC ANALYSIS OF FINCH 32020 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies
Daniel Aletaha, René Westhovens, Cécile Gaujoux-Viala, Giovanni Adami, A K Matsumoto, Paul Bird, +6 more
0citations